SRPT
Sarepta Therapeutics, Inc. · Healthcare
SVP Interim CEO, CMO Edward M. Md Kaye sold $737K of Sarepta Therapeutics, Inc.
Sold$736,710
$30.00Price
24,557Shares
−24%Stake
What SRPT did after the filing
Prices for SRPT after this filing aren't in yet.
Traded Wed, Sep 14. Filed Fri, Sep 16, 4:04 PM ET, after the close. Not investment advice.